Skip to main content

Advertisement

Log in

Prediction of clinical outcome by controlling nutritional status (CONUT) before allogeneic hematopoietic stem cell transplantation in myeloid malignancies

  • Original Article
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Malnutrition before allogeneic hematopoietic cell transplantation (allo-HCT) is associated with poor clinical outcomes. Herein, we evaluated the predictive value of controlling nutritional status (CONUT) in patients undergoing allo-HCT for myeloid malignancies. We retrospectively analyzed 200 patients with myeloid malignancies who underwent allo-HCT for the first time. We evaluated CONUT before the initiation of conditioning and compared malnourished patients (poor CONUT, n = 56) with non-malnourished patients (normal CONUT, n = 144). The cumulative incidence of non-relapse mortality within 100 days (early NRM) was significantly higher in the poor CONUT group than in the normal CONUT group [21.4% (95% CI: 11.8–33.0%) vs. 9.7% (95% CI: 5.6–15.2%); P = 0.025]. In multivariate analysis, poor CONUT was an independent and significant risk factor for early NRM [HR: 2.2 (95% CI: 1.0–4.7); P = 0.048]. The overall 1-year survival rate was significantly lower in the poor CONUT group than in the normal CONUT group [53.3% (95% CI: 39.4–65.4%) vs. 71.0% (95% CI: 62.7–77.7%); P = 0.005]. These findings suggest that CONUT before allo-HCT is a useful predictor of poor outcomes in patients with myeloid malignancies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. 2006;354:1813–26.

    Article  CAS  Google Scholar 

  2. Van Cutsem E, Arends J. The causes and consequences of cancer-associated malnutrition. Eur J Oncol Nurs. 2005;9:S51–63.

    Article  Google Scholar 

  3. August DA, Huhmann MB. A.S.P.E.N. clinical guidelines: nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation. J Parenter Enter Nutr. 2009;33:472–500.

    Article  Google Scholar 

  4. Baumgartner A, Bargetzi A, Zueger N, Bargetzi M, Medinger M, Bounoure L, et al. Revisiting nutritional support for allogeneic hematologic stem cell transplantation—A systematic review. Bone Marrow Transplant. 2017;52:506–13.

    Article  CAS  Google Scholar 

  5. Horsley P, Bauer J, Gallagher B. Poor nutritional status prior to peripheral blood stem cell transplantation is associated with increased length of hospital stay. Bone Marrow Transplant. 2005;35:1113–6.

    Article  CAS  Google Scholar 

  6. Iestra JA, Fibbe WE, Zwinderman AH, van Staveren WA, Kromhout D. Body weight recovery, eating difficulties and compliance with dietary advice in the first year after stem cell transplantation: a prospective study. Bone Marrow Transplant. 2002;29:417–24.

    Article  CAS  Google Scholar 

  7. Urbain P, Birlinger J, Lambert C, Finke J, Bertz H, Biesalski HK. Longitudinal follow-up of nutritional status and its influencing factors in adults undergoing allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2013;48:446–51.

    Article  CAS  Google Scholar 

  8. Isenring E, Cross G, Daniels L, Kellett E, Koczwara B. Validity of the malnutrition screening tool as an effective predictor of nutritional risk in oncology outpatients receiving chemotherapy. Support Care Cancer. 2006;14:1152–6.

    Article  Google Scholar 

  9. Fuji S, Takano K, Mori T, Eto T, Taniguchi S, Ohashi K, et al. Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT. Bone Marrow Transplant. 2014;49:1505–12.

    Article  CAS  Google Scholar 

  10. Navarro WH, Loberiza FR, Bajorunaite R, van Besien K, Vose JM, Lazarus HM, et al. Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2006;12:541–51.

    Article  Google Scholar 

  11. Doney K, McMillen K, Buono L, et al. Impact of body mass index on outcomes of hematopoietic stem cell transplantation in adults. Biol Blood Marrow Transplant. 2019;25:613–20.

    Article  Google Scholar 

  12. de Barritta DRL, Bordalejo A, Cañueto I, Villar A, Navarro E. Evolution of nutritional status in patients with autologous and allogeneic hematopoietic stem cell transplant. Support Care Cancer. 2015;23:1341–7.

    Article  Google Scholar 

  13. El-Ghammaz AMS, Ben Matoug R, Elzimaity M, Mostafa N. Nutritional status of allogeneic hematopoietic stem cell transplantation recipients: influencing risk factors and impact on survival. Support Care Cancer. 2017;25:3085–93.

    Article  Google Scholar 

  14. De Ulíbarri JI, González-Madroño A, De Villar NGP, González P, González B, Mancha A, et al. CONUT: a tool for controlling nutritional status. first validation in a hospital population. Nutr Hosp. 2005;20:38–45.

    Google Scholar 

  15. Miyashita E, Konuma T, Kataoka J, et al. The prognostic impact of pretransplantation inflammatory and nutritional status in adult patients after myeloablative single cord blood transplantation. Biol Blood Marrow Transplant. 2019;25:981–8.

    Article  Google Scholar 

  16. Ballen K, Joffe S, Brazauskas R, et al. Hospital length of stay in the first 100 days after allogeneic hematopoietic cell transplantation for acute leukemia in remission: comparison among alternative graft sources. Biol Blood Marrow Transplant. 2014;20:1819–27.

    Article  Google Scholar 

  17. Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8.

    Article  CAS  Google Scholar 

  18. Iseki Y, Shibutani M, Maeda K, Nagahara H, Ohtani H, Sugano K, et al. Impact of the preoperative controlling nutritional status (CONUT) score on the survival after curative surgery for colorectal cancer. PLoS One. 2015;10:e0132488.

    Article  Google Scholar 

  19. Toyokawa T, Kubo N, Tamura T, Sakurai K, Amano R, Tanaka H, et al. The pretreatment controlling nutritional status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study. BMC Cancer. 2016;16:722.

    Article  Google Scholar 

  20. Fukushima K, Ueno Y, Kawagishi N, Kondo Y, Inoue J, Kakazu E, et al. The nutritional index ‘CONUT’ is useful for predicting long-term prognosis of patients with end-stage liver diseases. Tohoku J Exp Med. 2011;224:215–9.

    Article  Google Scholar 

  21. Bharadwaj S, Ginoya S, Tandon P, Gohel TD, Guirguis J, Vallabh H, et al. Malnutrition: laboratory markers vs nutritional assessment. Gastroenterol Rep. 2016;4:272–80.

    Google Scholar 

  22. Artz AS, Logan B, Zhu X, Akpek G, Bufarull RM, Gupta V, et al. The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes. Haematologica. 2016;101:1426–33.

    Article  CAS  Google Scholar 

  23. Fujino M, Kim Y, Ito M, et al. Intestinal thrombotic microangiopathy induced by FK506 in rats. Bone Marrow Transplant. 2007;39:367–72.

    Article  CAS  Google Scholar 

  24. Nishida T, Hamaguchi M, Hirabayashi N, et al. Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease. Bone Marrow Transplant. 2004;33:1143–50.

    Article  CAS  Google Scholar 

  25. Yamamoto W, Fujii E, Matsumoto K, et al. Prognostic value of pretransplant serum C-reactive protein in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. Int J Hematol. 2016;103:444–52.

    Article  CAS  Google Scholar 

  26. Patel A, Szydlo RM, Auner HW, et al. C-reactive protein prior to myeloablative allogeneic haematopoietic cell transplantation identifies patients at risk of early and long term mortality. Br J Haematol. 2018;180:889–92.

    Article  Google Scholar 

  27. Kuzu OF, Noory MA, Robertson GP. The role of cholesterol in cancer omer. Cancer Res. 2016;76:2063–70.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This research was founded by Japanese Red Cross Nagoya 1st. Hospital Research Grant NFRCH19-0002. We thank the medical, nursing, and clinical staffs for their important contributions to this study and their dedicated care of the patients.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hiroaki Araie.

Ethics declarations

Conflicts of interests

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Araie, H., Kawaguchi, Y., Okabe, M. et al. Prediction of clinical outcome by controlling nutritional status (CONUT) before allogeneic hematopoietic stem cell transplantation in myeloid malignancies. Int J Hematol 110, 599–605 (2019). https://doi.org/10.1007/s12185-019-02723-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-019-02723-w

Keywords

Navigation